Alterity Therapeutics (ATHE) Assets Average (2009 - 2026)

Alterity Therapeutics has reported Assets Average for 18 years, with the latest figure at $35.0 million in Q2 2026.

• On a quarterly basis, Assets Average rose 92.49% year-over-year to $35.0 million in Q2 2026; TTM through Jun 2026 was $35.0 million, a 92.49% increase from a year earlier, with the FY2026 full-year figure at $31.1 million, changed N/A from the prior year.
• Assets Average was $35.0 million for Q2 2026 at Alterity Therapeutics, up from $33.4 million in the prior quarter.
• The five-year high for Assets Average was $35.0 million in Q2 2026, with the low at $3.5 million in Q4 2024.
• Average Assets Average over 5 years is $19.2 million, with a median of $18.2 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2025: Assets Average slumped 71.45% in 2023, then jumped 842.92% in 2025.
• Over 5 years, Assets Average stood at $25.8 million in 2022, then tumbled by 71.45% to $7.4 million in 2023, then slumped by 51.84% to $3.5 million in 2024, then surged by 842.92% to $33.4 million in 2025, then climbed by 4.74% to $35.0 million in 2026.
• The last three Assets Average figures came in at $35.0 million (Q2 2026), $33.4 million (Q4 2025), and $18.2 million (Q2 2025), per Business Quant data.